Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Rheumatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Rheumatology Other
    Adalimumab Decreases Rate of Anterior Uveitis in Ankylosing Spondylitis: Presented at AAO - (DGDispatch)
    Studies Examine Efficacy of Febuxostat in Gout, Protective Effects of Uric Acid - (DGNews)
    Adalimumab Does Not Inhibit Radiographic Progression in Ankylosing Spondylitis After 2 Years of Treatment: Presented at ACR-ARHP - (DGDispatch)
    Allopurinol Treatment May Reduce Mortality Risk in Hyperuricaemic Patients: Presented at ACR-ARHP - (DGDispatch)
    Pegloticase Shows Efficacy for Gout Symptoms: Presented at ACR-ARHP - (DGDispatch)

    News archive

     Recent webcasts/CME - Rheumatology Other
      B-Cell Biology and B-Cell-Targeted Therapies for Autoimmune Rheumatic Diseases: The Role of the Allied Health Professional
      Advances in B-Cell Biology in the Treatment of Autoimmune and Inflammatory Diseases
      Neuroinflammatory Diseases in Rheumatology
      Headache in Patients with Rheumatic Disease: When to Worry
      CNS Vasculitis

      Webcasts/CME archive

       Recent cases - Rheumatology Other
        Takayasu Arteritis in Children
        An Adolescent with Both Wegener's Granulomatosis and Chronic Blastomycosis
        Dysphagia Secondary to Dermatomyositis Treated Successfully with Intravenous Immunoglobulin: A Case Report
        F-18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for the Diagnosis of Takayasu's Arteritis in Stroke: A Case Report
        Sigmoid Sinus Thrombosis Presenting with Posterior Alexia in a Patient with Behcet's Disease And Polycythaemia: A Case Report

        Cases archive
          




        my personal edition > rheumatology other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Study Supports Potential of Nonsteroidal Anti-inflammatory Drugs to Protect Against Alzheimer's

        A DGReview of :"Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies"
        British Medical Journal (BMJ)

        07/22/2003
        By Joene Hendry


        Nonsteroidal anti-inflammatory drugs (NSAIDs) offer some reduction in the risk of developing Alzheimer's disease but the optimal dosage and duration of use is not yet known.

        Mahyar Etminan, an epidemiologist at Royal Victoria Hospital, Montreal, Canada and colleagues conducted an updated meta-analysis to quantify the risk of developing Alzheimer's disease in individuals using NSAIDs and, specifically, aspirin.

        Of the nine studies of any NSAID use in people over the age of 55 years, six were cohort studies including 13,221 participants and three were case-control studies including 1,443 participants.

        The pooled combined data from the cohort and case-control studies showed a relative risk of Alzheimer's disease was 0.72 among NSAID users.

        The analysis specific to aspirin users included eight studies that showed a pooled relative risk of 0.87 for developing Alzheimer's disease.

        Among subjects using NSAIDs for less than 1 month, the relative risk for developing Alzheimer's disease was 0.95 while for those using NSAIDs for an intermediate duration (less than 24 months in most cases) the relative risk was 0.83.

        The greatest benefit was seen in patients who used NSAIDs for more than 24 months, who had a relative risk for developing Alzheimer's disease of 0.27.

        While the meta-analysis indicated a protective effect from developing Alzheimer's disease with aspirin use, the investigators note that this protection was not significant, presumably due to the small number of studies that specifically evaluated the effects of aspirin.

        The investigators conclude that this systematic review supports the hypothesis that NSAID use may protect against the development of Alzheimer's disease. "The appropriate dose, duration, and ratios of risk to benefit are still unclear," they add.
        BMJ 2003;327:7407:128-31. "Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send